US Food and Drug Regulator Completes Check at Zydus Facility in Britain

Zydus Lifesciences announced that the American health regulator has finished checking its LiqMeds facility located in Britain. The inspection resulted in four observations from the visiting officials.

Inspection Details

The official check took place over a period of five days, running from November 9 to November 13. The company officially shared this update through a regulatory filing submitted to stock exchanges. Ahmedabad-based Zydus Lifesciences stated that it will work closely with the agency to clear up the points raised as quickly as possible. The disclosure was made under specific listing rules set by market regulators.

Background

The LiqMeds Group became a part of Zydus Lifesciences back in October 2023. The acquisition was carried out through a subsidiary of the firm known as Zydus Pharmaceuticals U.K.

Context

Health regulators regularly inspect manufacturing sites to ensure facilities maintain high quality and safety standards for products supplied to markets. When inspectors note issues, companies typically get time to fix the points raised and submit formal responses to the regulatory body.